hg_240454.1

Basic information about the TSS

---

TSS ID: hg_240454.1 Species: human Chr: chr3		Start: 9470903 End: 9470920 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000486465.5 Distance: -237 GeneID: 55209 HGNC/MGI_ID: HGNC:25566 UniProt_ID:

Gene_name: SET domain containing 5 Gene_symbol: SETD5 Gene_synonyms: FLJ10707 Gene_source: HGNC:25566

TATA-Box annotation

---

Distance to TSS:	16
Nearest PromoterID:	NM_181573
Entrez ID:	5984
Nearest Unigene:	Hs.732098
Nearest Refseq:	NM_002916
Nearest Ensembl:	ENSG00000163918
Gene Name:	SET domain containing 5
Gene Alias:	A1|RFC37
Gene Description:	replication factor C subunit 4
Gene Type:	protein-coding
CpG%:	0.07
GC%:	0.636816
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SETD5 p2@SETD5 p3@SETD5 p6@SETD5
Sample		p1@SETD5	p2@SETD5	p3@SETD5	p6@SETD5
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	29.22	12.08	6.82	4.29
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	27.92	14.77	6.47	4.65
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	22.18	12.35	4.24	5.79
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	17.05	7.48	3.95	3.74
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	20.92	8.55	4.72	2.70
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	18.99	10.27	4.65	2.33
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	25.71	6.54	4.14	4.14
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	23.98	12.35	5.57	2.91
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	23.30	10.69	7.27	2.78
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	55.06	11.59	6.96	7.54
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	43.25	12.13	8.08	7.28
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	54.88	14.23	10.57	6.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	29.01	3.71	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	15.64	3.16	0.30	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	24.37	2.20	0.66	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	20.87	3.77	0.50	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	17.91	3.06	1.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	16.87	2.95	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	16.53	3.73	1.60	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	15.04	3.16	0.90	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	14.43	4.68	0.40	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	15.54	4.49	1.38	1.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	16.29	3.23	0.78	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	18.93	3.64	1.21	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	17.29	4.39	1.29	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	16.14	4.75	1.58	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	14.29	4.40	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	20.75	5.66	1.65	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	14.38	6.30	1.29	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	17.19	4.89	0.72	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	12.77	5.23	1.67	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	13.87	5.86	0.98	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	9.92	5.49	1.27	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	8.58	7.09	2.47	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	9.54	4.67	0.37	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	12.07	5.56	1.15	1.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	19.42	6.54	1.64	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	12.09	5.24	1.41	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	12.69	5.40	1.08	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	18.00	7.44	1.20	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	15.06	6.59	2.12	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	11.13	5.27	1.61	1.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	19.19	6.12	1.90	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	18.71	6.64	1.92	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	22.69	6.42	1.00	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	24.20	7.44	0.93	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	25.91	7.92	1.92	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	17.58	8.05	1.19	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	21.78	9.10	1.91	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	15.97	8.90	2.22	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	18.45	10.45	1.84	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	23.57	14.01	2.22	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	13.99	27.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	12.77	12.77	2.13	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	13.26	11.27	0.33	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	11.75	7.55	7.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	10.56	9.64	1.84	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	14.58	15.88	1.30	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	12.85	10.92	1.28	2.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	17.29	15.40	4.71	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	11.99	15.51	0.71	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	7.29	8.97	2.24	3.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	18.31	24.68	9.55	5.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	8.83	21.41	2.72	3.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	17.22	21.77	2.60	2.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	9.23	20.94	3.19	3.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	16.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	31.59	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	8.78	24.38	1.46	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	6.45	15.87	0.99	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	7.04	20.17	3.28	2.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	13.25	23.18	1.99	3.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	7.11	16.70	1.24	2.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	8.26	21.40	1.53	1.83
Adipocyte - breast, donor1	11376-118A8	8.39	4.12	0.63	0.16
Adipocyte - breast, donor2	11327-117E4	12.83	3.85	0.16	1.76
Adipocyte - omental, donor1	11473-119C6	10.05	6.49	1.27	1.15
Adipocyte - omental, donor2	11474-119C7	11.96	1.49	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	18.09	4.35	0.00	1.00
Adipocyte - perirenal, donor1	11476-119C9	7.66	3.83	0.00	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	11.00	2.20	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	3.16	1.35	0.90	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	14.60	0.52	0.35	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	11.34	13.10	1.37	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	20.08	11.58	2.06	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	16.45	9.20	1.39	1.95
Adipocyte differentiation, day04, donor4	13028-139E4	23.51	9.40	1.76	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	11.66	5.79	1.77	0.40
Adipocyte differentiation, day08, donor2	13023-139D8	20.01	4.52	2.90	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	9.06	4.27	1.60	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	18.92	4.45	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	14.97	2.91	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	16.07	3.77	1.00	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	15.71	3.60	0.98	0.98
Adipocyte differentiation, day12, donor4	13030-139E6	9.74	3.65	0.61	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	4.42	7.29	0.88	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	5.02	2.87	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	7.19	2.40	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	8.64	6.84	1.62	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	13.39	3.35	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	14.59	3.70	0.41	0.00
Anulus Pulposus Cell, donor1	11248-116E6	11.56	3.32	0.92	0.11
Anulus Pulposus Cell, donor2	11463-119B5	24.74	2.20	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	8.54	6.29	0.45	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	7.38	3.91	0.00	2.17
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	2.14	6.42	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	5.08	4.18	1.49	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	2.53	7.59	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	3.96	1.98	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	3.90	5.52	1.62	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	6.31	2.91	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	4.75	1.19	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	5.65	3.77	0.00	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	5.81	6.53	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	3.76	0.00	2.51	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	4.28	3.95	1.65	0.82
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	5.46	9.55	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	4.67	4.37	0.45	0.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	6.97	5.36	0.00	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	4.91	5.86	0.57	0.94
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	7.75	6.41	0.53	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	6.83	6.83	0.00	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	5.47	6.47	0.50	0.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	4.80	3.60	2.40	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	5.49	5.83	0.69	0.86
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	4.37	7.77	0.97	2.43
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	6.83	6.45	0.76	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	3.63	2.42	0.00	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	10.26	6.27	0.00	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	5.77	3.21	0.43	0.86
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	4.90	6.71	0.26	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	3.75	5.63	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	6.11	5.47	1.29	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	6.42	4.99	0.71	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	1.17	4.68	0.58	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	4.52	6.32	0.60	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	9.50	1.19	2.38	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	4.58	6.10	0.51	2.03
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	4.58	3.31	1.02	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	8.26	3.81	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	7.34	3.88	0.86	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	5.08	4.23	0.21	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	4.93	4.93	0.29	1.16
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	5.67	6.61	0.94	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	4.58	5.93	0.51	0.85
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	4.23	8.45	0.00	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	5.79	3.00	0.43	0.86
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	7.22	0.00	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	4.37	3.64	0.73	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	5.06	6.21	1.38	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	0.00	7.65	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	4.07	5.59	0.76	1.02
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	6.40	6.81	0.83	1.65
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	7.04	5.51	0.92	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	5.74	11.95	0.96	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	6.87	4.88	0.67	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	1.53	9.15	0.00	3.05
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	6.09	5.54	1.66	1.66
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	4.50	6.62	0.53	1.06
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	5.09	5.45	0.73	1.09
Astrocyte - cerebellum, donor1	11500-119F6	10.69	5.16	1.23	0.86
Astrocyte - cerebellum, donor2	11580-120F5	15.23	3.08	0.51	0.86
Astrocyte - cerebellum, donor3	11661-122F5	16.57	2.52	1.05	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	21.26	12.20	3.83	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	30.74	11.65	2.10	0.97
Astrocyte - cerebral cortex, donor3	11392-118C6	22.37	13.72	2.83	1.19
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	41.97	22.13	4.36	2.06
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	39.09	23.05	3.13	2.26
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	38.69	21.39	2.28	1.02
Basophils, donor1	12241-129G9	4.71	7.06	3.14	0.26
Basophils, donor2	12242-129H1	6.13	7.22	5.77	0.72
Basophils, donor3	12243-129H2	11.17	13.67	5.29	1.76
Bronchial Epithelial Cell, donor1	11511-119G8	6.68	3.88	1.08	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	5.03	4.11	0.00	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	8.16	6.28	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	9.57	9.15	1.04	1.46
Bronchial Epithelial Cell, donor6	11461-119B3	5.76	10.82	0.46	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	18.53	5.76	1.26	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	19.99	6.90	1.44	0.82
Burkitt's lymphoma cell line:RAJI	10476-106I8	16.07	23.52	6.52	1.63
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	15.99	6.40	3.20	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	5.64	15.78	9.02	3.94
CD14+ Monocytes, donor2	11305-117B9	9.65	19.86	5.94	5.75
CD14+ Monocytes, donor3	11381-118B4	9.88	20.42	4.39	2.63
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	18.96	3.11	0.57	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	21.61	5.31	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	26.96	4.27	0.00	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	26.02	8.53	4.05	1.30
CD14+ monocytes - mock treated, donor2	11873-125C1	18.71	14.18	3.62	3.02
CD14+ monocytes - mock treated, donor3	11883-125D2	25.82	11.13	4.50	3.79
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	21.09	11.55	4.69	3.01
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	24.29	21.80	7.18	6.07
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	19.83	19.34	6.20	7.44
CD14+ monocytes - treated with BCG, donor1	11860-125A6	19.78	7.64	4.50	3.72
CD14+ monocytes - treated with BCG, donor2	11870-125B7	25.64	7.12	5.34	3.20
CD14+ monocytes - treated with BCG, donor3	11880-125C8	14.36	17.41	9.14	4.13
CD14+ monocytes - treated with Candida, donor1	11868-125B5	13.81	6.09	3.98	1.87
CD14+ monocytes - treated with Candida, donor2	11878-125C6	15.31	14.26	5.28	4.75
CD14+ monocytes - treated with Candida, donor3	11888-125D7	12.20	13.31	7.77	3.33
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	18.30	11.60	5.06	2.38
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	18.96	17.36	6.39	5.79
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	10.20	21.24	4.58	5.41
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	15.56	10.98	4.35	2.75
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	15.83	12.89	6.56	3.17
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	11.35	12.66	2.18	3.49
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	27.44	8.61	2.15	1.88
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	21.46	10.64	5.06	2.79
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	33.24	12.20	8.42	3.79
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	15.25	12.12	8.45	4.23
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	20.08	28.18	9.86	7.75
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	25.45	25.01	9.21	10.09
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	25.98	9.59	4.71	2.96
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	22.30	8.55	9.66	4.46
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	23.93	17.68	8.19	3.23
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	20.88	11.47	4.91	1.23
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	18.31	17.38	12.29	7.65
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	12.06	17.17	6.73	5.80
CD14+CD16+ Monocytes, donor1	11789-124B7	6.76	1.74	1.31	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	8.32	4.16	3.46	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	7.15	1.73	2.38	0.87
CD14+CD16- Monocytes, donor1	11788-124B6	15.42	4.36	2.02	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	9.95	5.76	1.40	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	20.29	6.02	1.56	1.78
CD14-CD16+ Monocytes, donor1	11790-124B8	13.27	1.28	0.77	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	8.12	2.20	1.10	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	8.42	1.47	0.63	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	30.48	4.06	8.13	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	37.97	3.39	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	34.17	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	25.05	2.13	4.26	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	35.92	3.22	3.22	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	35.80	1.40	2.11	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	26.67	3.14	1.57	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	26.37	1.32	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	30.41	5.75	4.93	0.82
CD19+ B Cells, donor2	11624-122B4	17.41	10.88	3.63	0.00
CD19+ B Cells, donor3	11705-123B4	25.24	6.06	5.05	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	24.24	8.49	2.83	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	10.39	4.79	1.20	0.00
CD34+ Progenitors, donor1	11545-120B6	11.04	31.13	4.02	8.03
CD34+ Progenitors, donor2	11625-122B5	5.62	29.21	11.24	12.92
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	15.78	3.76	0.75	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	14.66	5.86	3.16	0.45
CD4+ T Cells, donor1	11225-116C1	22.14	5.71	3.21	0.00
CD4+ T Cells, donor2	11306-117C1	23.88	7.35	3.67	0.00
CD4+ T Cells, donor3	11382-118B5	21.35	3.05	1.83	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	19.14	5.36	2.55	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	24.26	2.47	3.14	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	29.61	5.75	1.44	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	28.92	2.37	3.32	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	40.73	0.70	4.21	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	32.96	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	13.87	5.35	3.03	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	27.45	4.24	2.03	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	26.76	5.16	2.10	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	20.62	2.69	0.90	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	15.37	2.45	2.80	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	28.16	2.20	3.08	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	28.25	5.90	2.53	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	37.61	4.99	1.66	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	32.41	5.01	2.67	1.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	44.87	1.90	1.63	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	75.03	1.61	3.22	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	48.42	1.79	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	28.00	7.23	2.78	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	25.99	5.42	1.73	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	27.53	4.20	1.26	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	34.38	3.03	4.55	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	25.56	0.87	3.03	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	27.02	3.05	1.31	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	44.54	3.96	2.47	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	34.16	1.85	4.62	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	39.08	1.40	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	41.54	1.94	3.60	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	40.98	3.93	1.47	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	35.42	4.62	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	38.32	5.01	0.36	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	40.16	4.15	2.77	0.00
CD8+ T Cells, donor1	11226-116C2	19.32	9.49	7.86	1.64
CD8+ T Cells, donor2	11307-117C2	22.90	5.63	6.76	1.13
CD8+ T Cells, donor3	11383-118B6	21.97	7.07	6.31	1.01
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	8.72	25.00	1.84	5.28
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	7.43	23.25	1.92	6.23
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	4.92	21.61	1.09	2.19
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	2.10	23.72	3.00	4.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	6.00	21.12	2.88	4.56
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	4.55	19.78	0.68	4.55
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	4.35	23.47	1.30	6.08
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	3.95	21.32	1.32	6.32
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	2.58	23.22	3.05	5.39
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	3.92	30.49	1.21	9.96
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	1.45	33.41	2.91	6.97
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	3.20	32.50	4.00	6.39
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	3.94	36.33	0.88	11.82
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	0.46	28.24	2.28	15.48
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	3.73	37.29	0.00	20.14
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	6.12	24.49	1.44	3.60
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	6.33	17.84	0.58	4.32
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	4.01	20.74	1.65	2.83
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	2.54	28.52	1.58	6.02
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	4.00	27.99	1.23	6.15
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	4.17	26.93	1.92	4.49
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	3.44	30.98	0.76	11.09
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	3.55	24.04	4.73	11.43
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	3.03	28.74	1.51	4.54
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	10.44	65.84	2.41	27.30
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	9.09	70.64	4.90	21.68
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	8.01	83.15	4.01	22.04
Cardiac Myocyte, donor1	11525-119I4	51.18	7.31	3.66	0.00
Cardiac Myocyte, donor2	11605-120I3	11.36	4.94	1.48	0.99
Cardiac Myocyte, donor3	11686-122I3	5.26	4.31	1.05	0.32
Chondrocyte - de diff, donor1	11261-116G1	15.25	7.63	0.69	1.73
Chondrocyte - de diff, donor2	11338-117F6	10.66	2.13	1.78	1.07
Chondrocyte - de diff, donor3	11410-118E6	13.99	2.39	0.34	0.23
Chondrocyte - re diff, donor2	11339-117F7	1.79	22.38	1.79	8.06
Chondrocyte - re diff, donor3	11411-118E7	27.50	10.92	3.64	1.62
Ciliary Epithelial Cells, donor1	11242-116D9	17.21	9.64	3.44	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	14.32	12.83	2.57	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	18.23	8.76	2.57	0.71
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	22.65	5.23	1.93	0.73
Corneal Epithelial Cells, donor1	11526-119I5	4.61	3.73	0.22	0.00
Corneal Epithelial Cells, donor2	11606-120I4	11.38	6.83	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	7.16	9.46	0.51	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	12.55	6.11	0.50	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	12.93	4.73	0.63	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	14.58	4.97	0.54	0.54
Dendritic Cells - plasmacytoid, donor1	11228-116C4	12.98	9.91	5.47	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	8.49	14.36	8.49	3.92
Dendritic Cells - plasmacytoid, donor3	11385-118B8	12.58	8.71	4.84	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	3.84	10.01	2.17	1.50
Endothelial Cells - Aortic, donor1	11263-116G3	5.28	4.11	1.76	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	3.11	8.77	0.28	2.26
Endothelial Cells - Aortic, donor3	11412-118E8	7.47	7.86	0.39	1.97
Endothelial Cells - Artery, donor1	11264-116G4	6.98	5.53	0.58	3.78
Endothelial Cells - Artery, donor2	11341-117F9	10.12	11.76	0.24	4.71
Endothelial Cells - Artery, donor3	11413-118E9	7.54	11.40	1.05	3.51
Endothelial Cells - Lymphatic, donor1	11236-116D3	7.98	5.98	1.55	1.33
Endothelial Cells - Lymphatic, donor2	11317-117D3	10.65	9.74	2.13	3.96
Endothelial Cells - Lymphatic, donor3	11393-118C7	13.53	11.84	4.51	2.26
Endothelial Cells - Microvascular, donor1	11265-116G5	3.27	5.94	1.19	1.49
Endothelial Cells - Microvascular, donor2	11342-117G1	3.12	5.73	0.52	4.69
Endothelial Cells - Microvascular, donor3	11414-118F1	8.22	6.81	1.84	1.56
Endothelial Cells - Thoracic, donor1	11266-116G6	6.80	9.60	1.20	6.00
Endothelial Cells - Thoracic, donor2	11343-117G2	11.01	9.96	2.10	2.10
Endothelial Cells - Umbilical vein, donor1	11243-116E1	10.31	15.78	3.48	4.22
Endothelial Cells - Umbilical vein, donor2	11324-117E1	13.04	7.60	1.96	1.74
Endothelial Cells - Umbilical vein, donor3	11400-118D5	10.14	12.70	1.34	4.89
Endothelial Cells - Vein, donor1	11267-116G7	6.83	11.38	0.00	3.41
Endothelial Cells - Vein, donor2	11344-117G3	3.49	9.78	2.10	1.40
Endothelial Cells - Vein, donor3	11416-118F3	7.85	10.68	1.57	1.10
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	36.31	24.75	16.50	23.10
Eosinophils, donor3	12246-129H5	10.70	35.67	7.13	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	6.84	5.13	1.95	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	2.08	0.00	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	7.39	13.96	0.41	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	5.26	2.52	0.11	0.55
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	10.83	2.93	0.65	0.54
Fibroblast - Aortic Adventitial, donor1	11245-116E3	4.49	8.73	1.46	1.94
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	27.98	22.65	3.82	3.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	8.96	6.43	0.74	1.16
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	35.57	15.02	2.11	2.63
Fibroblast - Aortic Adventitial, donor3	11401-118D6	13.95	12.96	0.00	1.00
Fibroblast - Cardiac, donor1	11268-116G8	15.88	8.17	0.45	1.36
Fibroblast - Cardiac, donor2	11345-117G4	8.34	9.85	1.52	4.55
Fibroblast - Cardiac, donor3	11417-118F4	5.99	6.47	0.47	0.95
Fibroblast - Cardiac, donor4	11452-119A3	20.01	17.88	1.52	1.52
Fibroblast - Cardiac, donor5	11456-119A7	10.41	12.69	0.76	3.17
Fibroblast - Cardiac, donor6	11460-119B2	7.88	16.07	1.06	2.12
Fibroblast - Choroid Plexus, donor1	11492-119E7	14.87	7.77	0.67	1.21
Fibroblast - Choroid Plexus, donor2	11572-120E6	22.43	11.65	1.73	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	14.65	2.93	1.46	2.93
Fibroblast - Conjunctival, donor1	11531-120A1	25.60	6.92	2.31	1.15
Fibroblast - Conjunctival, donor3	11692-122I9	24.59	4.75	2.04	0.00
Fibroblast - Dermal, donor1	11269-116G9	13.38	3.76	0.47	0.47
Fibroblast - Dermal, donor2	11346-117G5	9.43	5.19	0.47	0.94
Fibroblast - Dermal, donor3	11418-118F5	7.01	6.41	0.73	0.36
Fibroblast - Dermal, donor4	11450-119A1	18.99	10.17	0.45	0.57
Fibroblast - Dermal, donor5	11454-119A5	21.81	12.91	1.40	0.87
Fibroblast - Dermal, donor6	11458-119A9	23.39	12.99	0.49	1.14
Fibroblast - Gingival, donor1	11237-116D4	13.53	5.83	1.25	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	22.01	12.58	1.31	1.05
Fibroblast - Gingival, donor2	11318-117D4	16.47	11.07	1.58	0.66
Fibroblast - Gingival, donor3	11394-118C8	25.43	5.32	0.19	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	13.51	10.39	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	17.62	6.52	0.88	0.88
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	19.18	12.16	0.78	3.27
Fibroblast - Gingival, donor6 (control)	11922-125H5	13.12	9.20	0.95	1.49
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	50.81	16.23	2.82	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	17.84	9.80	1.32	1.61
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	18.82	8.32	1.23	0.68
Fibroblast - Gingival, donor8 (control)	11926-125H9	13.27	16.56	0.99	2.63
Fibroblast - Gingival, donor9 (control)	11927-125I1	29.20	7.63	0.88	0.59
Fibroblast - Lung, donor1	11270-116H1	5.44	6.80	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	22.38	5.97	2.98	1.49
Fibroblast - Lung, donor3	11419-118F6	12.45	5.91	0.84	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	10.83	4.17	0.83	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	6.99	2.80	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	3.08	2.24	0.00	0.28
Fibroblast - Mammary, donor1	11540-120B1	19.08	12.18	3.25	1.22
Fibroblast - Mammary, donor2	11620-122A9	7.99	11.98	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	35.74	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	13.58	13.38	3.30	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	28.67	14.86	2.43	1.06
Fibroblast - Periodontal Ligament, donor3	11395-118C9	13.46	15.30	1.22	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	17.94	8.40	0.00	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	13.23	10.53	1.08	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	18.09	4.87	0.58	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	3.43	8.51	1.44	1.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	10.97	10.57	1.63	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	12.03	7.35	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	14.63	4.74	1.19	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	31.95	22.42	2.58	5.95
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	13.32	4.26	0.89	0.89
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	12.61	12.02	2.37	1.58
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	27.08	17.15	1.81	2.11
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	14.57	9.61	0.32	1.51
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	37.46	17.46	2.28	3.29
Fibroblast - skin normal, donor1	11553-120C5	10.50	8.53	0.82	0.66
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	24.86	41.30	4.81	9.82
Fibroblast - skin normal, donor2	11561-120D4	9.54	11.95	0.80	2.11
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	40.50	24.78	4.23	4.84
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	18.06	7.37	1.33	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	20.00	5.81	1.37	0.85
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	29.23	11.82	3.61	2.63
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	7.24	8.52	0.53	2.13
Fibroblast - skin walker warburg, donor1	11554-120C6	6.92	12.99	1.35	3.04
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	8.78	4.70	1.25	0.78
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	44.32	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	19.17	7.84	7.84	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	8.49	4.33	0.87	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	5.20	15.35	1.04	1.56
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	12.01	5.88	2.30	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	49.00	16.84	3.06	2.30
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	37.65	15.95	4.47	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	65.04	7.42	2.28	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	91.00	24.54	7.17	1.10
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	54.80	20.32	3.42	2.05
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	86.19	12.09	2.77	1.19
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	85.64	16.65	4.76	1.32
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	67.84	18.26	4.24	2.61
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	84.02	9.29	1.33	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	60.49	9.75	2.69	1.41
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	60.22	7.76	2.83	1.48
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	46.20	6.18	1.34	2.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	47.82	6.32	3.96	1.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	46.10	7.20	3.05	0.97
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	39.64	5.69	1.22	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	42.21	7.53	2.28	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	35.75	5.98	2.49	1.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	65.14	8.96	1.75	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	38.41	3.25	1.48	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	48.48	5.40	3.02	0.79
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	50.94	7.37	1.79	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	42.75	4.44	1.61	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	37.49	8.48	3.05	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	32.19	10.37	2.48	1.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	37.15	7.80	2.60	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	28.35	5.29	2.05	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	49.24	7.97	2.21	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	33.69	10.73	3.41	1.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	30.83	8.58	3.27	1.02
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	41.26	6.19	2.06	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	52.00	7.15	2.08	0.81
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	40.36	9.34	1.67	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	44.09	4.19	1.32	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	46.61	5.04	1.84	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	38.90	7.78	1.78	1.46
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	51.96	4.49	3.21	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	37.90	5.50	2.75	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	29.90	5.06	1.74	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	33.15	5.47	2.43	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	37.63	7.00	2.82	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	37.54	5.93	1.10	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	42.08	7.29	3.37	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	27.31	10.18	1.57	0.37
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	19.52	8.29	0.53	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	18.51	8.57	1.07	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	17.23	9.20	2.59	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	27.92	8.95	1.90	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	28.39	7.56	2.58	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	25.44	9.65	1.75	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	63.47	4.96	1.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	22.03	12.66	3.03	1.45
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	22.60	7.26	1.21	1.21
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	40.67	13.47	2.80	0.76
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	56.13	7.76	1.79	1.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	73.19	5.85	2.16	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	93.09	8.59	4.09	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	25.97	13.14	3.13	1.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	22.60	9.04	1.98	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	32.75	14.76	0.92	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	22.27	14.85	0.00	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	32.88	19.34	1.93	3.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	48.13	17.65	1.60	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	48.69	20.87	8.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	30.92	12.04	2.93	2.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	30.47	16.06	2.88	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	49.98	26.66	16.66	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	40.83	12.86	2.24	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	34.65	13.40	3.27	1.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	63.75	16.78	7.55	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	43.89	14.95	5.41	1.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	34.65	12.23	1.70	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	43.85	16.71	6.26	4.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	45.24	14.89	2.86	2.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	29.60	9.47	3.26	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	37.27	13.55	3.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	25.27	17.40	4.56	4.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	29.46	14.27	4.37	2.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	26.34	21.07	10.54	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	25.37	13.84	3.46	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	21.84	15.97	4.56	3.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	39.46	8.69	6.69	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	45.08	8.09	5.39	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	45.53	23.28	7.19	3.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	72.06	22.36	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	72.66	8.97	2.36	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	58.54	9.66	4.83	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	62.06	11.19	5.09	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	42.28	13.16	3.59	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	42.43	8.88	3.45	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	87.35	9.44	2.36	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	40.84	14.00	4.08	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	68.03	12.29	4.39	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	61.88	17.80	6.78	4.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	29.85	13.13	4.18	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	20.38	7.76	0.49	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	11.41	12.55	2.28	2.28
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	12.89	9.15	1.25	2.08
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	16.87	11.24	1.12	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	15.86	2.22	2.22	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	8.77	0.42	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	9.28	9.40	1.51	1.28
Hep-2 cells mock treated, biol_rep2	11899-125E9	10.80	10.47	1.86	1.52
Hep-2 cells mock treated, biol_rep3	11900-125F1	9.33	8.19	0.46	0.91
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	12.68	8.42	0.55	0.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	10.96	5.59	0.86	1.07
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	10.12	9.26	1.72	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	8.47	6.97	0.75	0.87
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	8.41	6.18	0.34	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	7.05	7.05	0.96	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	16.23	5.04	0.56	1.68
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	8.22	5.63	0.43	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	2.64	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	9.17	3.88	0.35	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	8.72	5.81	1.45	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	5.59	8.57	0.35	1.22
Hepatocyte, donor1	11523-119I2	31.48	4.84	0.00	1.21
Hepatocyte, donor2	11603-120I1	28.01	11.85	2.15	1.08
Hepatocyte, donor3	11684-122I1	48.47	10.43	2.45	2.45
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	48.30	3.92	3.26	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	18.00	13.98	1.92	1.22
Iris Pigment Epithelial Cells, donor1	11530-119I9	9.74	5.49	0.96	0.96
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	101.88	28.66	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	86.78	13.35	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	117.67	26.30	1.38	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	42.55	15.02	2.50	7.51
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	71.21	11.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	125.58	33.32	2.56	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	95.99	9.14	0.00	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	123.45	47.11	3.25	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	75.03	28.34	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	50.83	25.41	14.52	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	149.55	30.44	1.32	3.97
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	79.82	16.63	1.11	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	115.24	36.67	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	84.40	31.49	6.30	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	88.16	41.76	3.09	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	117.08	43.90	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	109.83	32.30	7.75	5.17
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	119.13	51.52	8.05	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	250.91	107.53	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	118.97	35.85	7.33	4.89
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	30.23	24.77	5.46	1.68
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	86.23	14.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	97.25	40.18	6.43	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	62.78	21.24	1.85	2.77
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	226.21	45.24	15.08	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	53.81	14.63	5.19	1.89
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	51.70	13.60	0.91	2.72
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	58.97	0.00	14.74
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	107.61	27.98	4.30	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	87.66	31.76	1.27	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	65.72	32.86	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	112.23	20.41	1.91	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	102.07	27.34	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	221.26	31.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	84.97	27.85	4.28	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	142.69	23.23	0.00	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	208.49	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	53.71	15.74	1.85	0.93
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	142.24	21.07	5.27	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	94.29	22.00	9.43	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	102.22	25.73	4.17	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	128.36	37.62	4.43	6.64
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	77.81	25.94	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	86.32	31.39	4.36	4.36
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	110.24	38.25	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	59.24	48.78	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	74.67	29.87	5.33	4.27
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	108.06	26.32	1.39	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	108.28	34.20	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	101.25	41.42	1.84	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	108.91	27.23	9.08	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	142.80	31.04	0.00	6.21
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	82.47	24.32	1.06	2.11
Keratinocyte - epidermal, donor1	11272-116H3	7.34	11.42	1.80	1.31
Keratinocyte - epidermal, donor2	11349-117G8	4.10	4.69	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	6.63	14.39	1.14	0.57
Keratinocyte - oral, donor1	11251-116E9	20.09	10.33	1.59	0.34
Keratocytes, donor1	11527-119I6	11.69	6.88	1.72	0.34
Keratocytes, donor2	11607-120I5	12.89	3.52	0.00	2.34
Keratocytes, donor3	11688-122I5	23.71	2.96	1.78	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	57.15	17.58	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	6.47	5.39	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	19.61	3.23	1.85	0.46
Lens Epithelial Cells, donor3	11690-122I7	12.71	5.45	2.22	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	7.59	5.81	1.07	1.66
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	5.02	4.47	0.00	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	10.86	6.93	1.57	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	5.38	7.53	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	4.10	3.78	1.26	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	5.28	4.53	0.86	1.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	9.85	4.51	1.64	1.64
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	4.80	3.54	0.00	1.77
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	4.93	5.77	0.28	1.27
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	5.54	3.96	0.40	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	7.17	7.17	0.39	2.13
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	3.33	2.04	0.37	1.11
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	6.27	3.48	0.35	3.14
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	5.49	4.05	0.24	1.91
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	5.77	3.43	0.82	1.92
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	5.85	4.62	0.31	1.54
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	2.81	2.81	0.31	2.18
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	5.86	4.39	0.73	2.20
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	3.95	5.59	0.33	1.32
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	2.93	2.34	0.88	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	4.48	3.49	1.24	1.74
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	7.76	3.88	1.45	3.88
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	4.58	6.73	0.27	0.81
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	3.48	3.94	0.45	1.97
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	3.11	4.67	1.04	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	5.86	7.12	0.42	2.51
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	3.16	3.76	0.60	1.65
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	6.88	4.13	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	3.39	6.21	0.75	2.07
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	5.09	3.18	0.64	0.85
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	8.72	6.30	0.00	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	4.30	4.30	0.33	1.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	6.07	2.73	0.99	1.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	8.51	6.66	0.00	2.96
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	1.98	3.46	0.74	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	3.16	4.12	0.82	0.82
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	11.26	5.47	0.00	1.29
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	4.56	8.52	0.61	3.04
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	7.70	5.46	0.56	1.40
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	6.76	3.56	1.78	3.91
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	3.39	4.85	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	5.91	3.27	0.62	1.24
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	8.24	2.86	0.36	1.43
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	5.23	4.25	0.33	1.63
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	4.00	2.59	0.94	0.71
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	7.55	5.45	1.49	1.11
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	4.87	3.84	0.26	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	3.58	5.37	0.30	1.19
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	22.66	2.27	2.27	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	52.17	4.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	28.20	3.71	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	52.47	8.46	1.27	1.27
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	56.27	3.52	0.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	50.43	4.67	1.87	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	45.86	3.61	0.52	1.55
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	46.39	2.38	1.19	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	30.76	6.56	1.36	0.68
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	53.22	8.14	0.87	1.16
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	45.02	5.40	0.45	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	40.24	8.13	1.08	0.95
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	60.08	9.24	0.00	2.05
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	43.75	6.00	1.76	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	37.31	5.33	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	62.65	7.64	1.02	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	44.29	8.27	2.13	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	48.18	6.05	2.27	0.76
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	63.81	9.20	3.07	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	54.63	9.79	1.63	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	46.85	4.79	0.62	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	44.00	6.45	1.68	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	53.58	9.27	3.09	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	48.77	11.32	1.16	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	37.67	8.67	1.20	1.20
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	40.39	7.19	1.11	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	61.15	10.25	2.12	2.83
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	57.90	10.33	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	52.96	4.61	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	53.34	6.52	0.38	2.30
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	58.88	8.49	0.00	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	46.77	4.10	0.82	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	49.71	10.39	2.71	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	43.09	8.62	1.44	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	58.26	11.95	2.24	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	60.94	6.32	3.34	1.49
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	38.77	6.89	0.86	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	62.51	6.85	2.57	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	61.30	7.00	1.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	48.26	7.24	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	59.72	3.55	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	49.15	6.87	0.69	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	58.51	6.44	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	55.22	8.08	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	67.41	7.41	1.11	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	26.75	6.98	2.33	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	57.12	4.23	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	61.22	12.00	2.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	70.51	5.81	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	69.75	10.73	3.07	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	55.74	5.92	1.48	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	62.10	5.65	1.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	75.93	7.54	2.01	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	67.59	9.91	1.80	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	70.57	3.44	1.72	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	56.11	8.46	1.78	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	65.69	7.04	0.78	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	51.46	5.28	1.32	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	61.23	12.45	1.56	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	61.70	9.63	2.63	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	49.20	6.15	1.12	2.24
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	60.50	8.83	1.77	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	58.63	13.11	1.93	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	46.08	9.11	0.51	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	59.12	8.65	1.44	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	52.48	13.12	1.59	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	55.90	9.11	0.00	2.43
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	42.19	13.14	0.69	3.46
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	56.62	9.50	2.28	1.14
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	55.26	11.88	1.03	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	53.81	10.28	1.81	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	59.58	16.48	0.63	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	76.23	13.33	2.13	1.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	47.70	9.19	0.57	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	62.74	16.97	1.54	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	58.71	14.15	2.83	2.83
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	43.70	10.78	1.13	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	68.64	15.81	2.08	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	55.60	8.61	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	36.74	7.93	2.51	2.09
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	66.44	10.69	1.39	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	48.17	11.37	2.68	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	62.02	12.30	1.60	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	64.25	18.18	0.40	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	65.16	8.26	0.92	3.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	62.24	8.00	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	78.07	14.25	2.85	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	88.19	4.60	2.30	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	58.00	11.49	1.09	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	61.92	10.69	1.34	1.34
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	37.17	15.08	2.34	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	68.30	9.28	1.33	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	76.91	22.86	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	20.74	4.56	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	6.42	7.16	0.00	0.37
Macrophage - monocyte derived, donor3	11389-118C3	15.21	6.55	0.66	0.39
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	2.66	6.90	0.00	0.53
Mallassez-derived cells, donor2	11929-125I3	6.97	12.36	2.38	1.74
Mallassez-derived cells, donor3	11930-125I4	5.42	10.84	1.11	1.11
Mammary Epithelial Cell, donor1	11273-116H4	5.78	23.02	1.00	1.40
Mammary Epithelial Cell, donor2	11350-117G9	5.50	16.50	1.45	2.03
Mammary Epithelial Cell, donor3	11422-118F9	5.74	7.48	1.00	0.50
Mast cell - stimulated, donor1	11487-119E2	14.91	88.81	3.39	11.52
Mast cell, donor1	11563-120D6	15.36	11.14	4.22	0.87
Mast cell, donor2	11565-120D8	15.75	24.07	5.65	2.38
Mast cell, donor3	11566-120D9	13.51	25.21	4.95	3.83
Mast cell, donor4	11567-120E1	16.31	21.81	5.67	2.13
Mast cell, expanded and stimulated, donor5	11940-126A5	24.29	10.65	4.10	1.66
Mast cell, expanded and stimulated, donor8	11942-126A7	11.09	27.43	2.33	5.25
Mast cell, expanded, donor5	11939-126A4	18.13	6.88	1.72	0.80
Mast cell, expanded, donor8	11941-126A6	14.23	14.23	2.51	0.67
Melanocyte - dark, donor1	11502-119F8	6.77	5.97	0.80	1.29
Melanocyte - dark, donor2	11582-120F7	11.77	5.19	1.38	0.69
Melanocyte - dark, donor3	11663-122F7	8.77	8.04	1.38	0.51
Melanocyte - light, donor1	11274-116H5	5.64	6.82	0.47	0.24
Melanocyte - light, donor2	11351-117H1	4.09	3.41	0.00	0.00
Melanocyte - light, donor3	11423-118G1	17.34	11.27	0.87	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	11.35	7.18	0.94	0.52
Melanocyte, donor2 (MC+2)	12739-135I3	5.65	7.80	0.81	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	18.21	7.23	1.61	0.54
Meningeal Cells, donor1	11493-119E8	9.80	17.49	0.99	1.86
Meningeal Cells, donor2	11573-120E7	23.33	9.68	0.00	1.32
Meningeal Cells, donor3	11654-122E7	10.43	14.91	1.63	1.22
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	6.56	6.84	1.43	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	3.92	13.89	1.81	1.81
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	13.14	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	7.85	3.92	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	7.89	10.76	0.72	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	12.07	4.24	0.42	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	14.58	5.53	1.51	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	6.59	8.13	0.44	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	7.31	8.77	0.73	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	8.18	7.77	0.41	1.02
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	13.30	3.88	0.55	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	8.92	4.46	0.74	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	15.53	11.18	2.76	0.66
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	8.61	4.15	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	0.00	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	10.25	10.25	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	2.84	14.53	1.06	2.13
Mesenchymal stem cells - hepatic, donor0	11218-116B3	10.95	7.51	1.25	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	10.16	6.53	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	9.02	6.10	0.27	0.53
Mesothelial Cells, donor2	12156-128G5	3.00	4.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	12.65	3.83	0.79	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	8.10	1.35	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	12.56	2.22	0.00	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	8.24	6.77	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	17.29	6.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	8.99	2.48	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	4.15	3.73	0.62	1.24
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	7.76	4.50	0.75	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	8.38	6.05	0.47	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	9.55	2.24	0.41	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	8.71	4.36	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	25.65	17.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	1.77	0.88	1.77	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	5.32	4.94	0.00	1.14
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	7.90	1.32	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	5.73	3.82	0.85	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	5.52	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	9.54	2.68	0.30	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	18.44	3.35	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	6.52	4.27	0.50	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	6.89	4.04	0.71	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	3.87	2.76	0.55	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	5.30	4.14	0.69	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	5.05	6.10	0.84	0.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	7.75	5.50	0.20	1.22
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	3.22	2.36	0.64	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	5.56	4.67	0.00	1.11
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	3.50	6.35	0.88	1.10
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	7.10	4.56	0.51	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	6.63	0.00	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	4.89	5.16	1.09	0.82
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	5.59	4.41	0.29	1.47
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	3.27	4.36	1.09	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	2.40	2.88	0.96	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	7.20	5.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	12.34	8.23	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	7.51	4.51	1.50	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	12.23	6.12	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	3.94	5.69	0.88	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	9.93	0.00	0.00	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	9.61	11.53	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	4.21	10.66	0.50	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	4.87	3.48	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	13.26	6.63	0.00	4.42
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	2.74	8.21	1.71	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	2.63	5.25	0.88	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	8.88	3.20	1.42	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	4.21	9.82	0.56	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	4.16	7.48	0.83	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	5.24	9.32	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	5.13	6.94	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	4.17	9.18	0.83	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	8.31	6.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	5.12	7.97	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	9.40	6.36	0.28	0.55
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	3.37	6.74	0.78	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	6.86	5.58	0.43	1.72
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	12.07	12.07	1.27	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	5.87	7.21	0.80	1.60
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	8.68	6.59	0.30	1.50
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	9.75	5.79	0.57	0.57
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	5.73	7.33	0.96	2.23
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	5.53	4.86	0.44	1.11
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	11.38	8.34	1.52	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	6.25	8.81	1.99	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	8.85	7.62	0.49	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	23.46	7.17	3.26	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	7.64	3.82	0.88	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	8.94	5.77	0.29	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	8.24	5.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	9.23	7.74	1.19	0.89
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	3.56	3.56	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	11.50	2.30	0.66	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	5.26	0.00	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	8.50	1.98	0.59	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	15.83	1.86	0.00	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	9.76	4.13	0.75	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	11.19	1.33	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	8.71	2.26	0.45	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	10.31	1.47	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	7.69	2.56	0.37	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	10.89	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	6.41	1.07	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	7.07	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	4.64	2.11	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	2.72	12.26	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	3.18	3.81	0.64	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	4.05	3.24	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	7.55	6.04	0.00	9.06
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	79.94	17.13	22.84
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	19.57	61.99	0.00	26.10
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	9.50	14.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	112.94	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	7.32	9.26	2.59	1.08
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	14.11	8.88	1.05	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	20.02	6.01	1.33	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	23.79	7.51	0.83	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	59.13	17.87	2.09	1.52
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	39.90	15.96	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	8.84	8.16	0.00	1.36
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	16.54	0.00	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	14.65	6.28	1.26	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	18.13	8.37	0.00	1.39
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	26.48	4.05	1.08	1.35
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	34.90	7.78	1.05	0.84
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	12.91	5.46	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	36.81	6.23	1.62	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	16.77	5.44	1.13	1.13
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	48.66	7.02	0.65	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	27.89	5.10	1.28	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	19.10	5.83	1.06	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	18.01	5.40	1.20	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	58.42	5.91	2.95	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	27.32	3.90	1.14	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	42.16	6.53	1.59	0.88
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	18.28	4.92	1.41	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	29.88	4.14	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	25.71	5.78	1.29	1.29
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	44.84	6.21	2.76	1.72
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	53.10	7.59	10.11	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	44.78	5.79	1.78	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	27.10	3.81	1.27	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	46.28	5.22	1.19	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	22.75	3.00	0.86	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	18.06	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	43.32	4.67	0.67	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	41.03	7.21	0.45	1.35
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	16.27	6.75	0.79	1.19
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	22.29	3.71	1.86	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	48.43	8.32	1.14	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	23.14	5.54	0.65	1.96
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	56.22	3.05	0.00	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	41.16	5.88	0.90	2.71
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	20.28	7.06	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	21.28	2.66	0.00	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	31.75	6.45	0.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	28.33	4.21	0.77	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	48.39	5.75	0.60	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	26.08	5.97	1.11	1.33
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	16.94	6.10	0.68	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	35.77	10.22	10.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	32.92	6.10	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	29.27	3.15	1.26	2.20
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	35.41	2.42	1.51	1.21
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	19.78	5.54	0.00	2.37
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	65.75	7.94	2.27	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	15.17	0.00	0.00
Myoblast, donor1	11241-116D8	5.96	10.68	0.99	1.37
Myoblast, donor2	11322-117D8	18.22	9.01	0.58	0.77
Myoblast, donor3	11398-118D3	13.45	10.93	1.35	2.35
NK T cell leukemia cell line:KHYG-1	10777-110G3	9.05	6.86	1.17	0.29
Natural Killer Cells, donor1	11230-116C6	16.91	9.23	4.61	1.54
Natural Killer Cells, donor2	11311-117C6	23.82	10.25	7.24	2.11
Natural Killer Cells, donor3	11387-118C1	18.77	9.57	7.73	2.39
Neural stem cells, donor1	11275-116H6	33.03	16.33	5.44	1.45
Neural stem cells, donor2	11352-117H2	44.29	9.63	0.00	1.93
Neurons, donor1	11494-119E9	26.17	5.69	1.14	1.14
Neurons, donor2	11574-120E8	27.52	2.86	1.54	0.00
Neurons, donor3	11655-122E8	48.51	6.58	0.82	0.82
Neutrophils, donor1	11233-116C9	33.41	12.06	6.50	5.57
Neutrophils, donor2	11314-117C9	26.09	17.39	5.80	0.00
Neutrophils, donor3	11390-118C4	45.81	33.60	7.33	3.67
Nucleus Pulposus Cell, donor1	11252-116F1	19.71	4.16	0.71	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	23.44	2.60	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	20.06	2.01	0.00	0.20
Olfactory epithelial cells, donor1	11933-125I7	26.57	11.01	1.24	2.06
Olfactory epithelial cells, donor2	11934-125I8	22.15	9.55	0.87	1.16
Olfactory epithelial cells, donor3	11935-125I9	31.67	4.88	0.91	0.45
Olfactory epithelial cells, donor4	11936-126A1	39.84	5.94	1.46	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	14.44	10.23	1.20	0.60
Osteoblast - differentiated, donor1	11276-116H7	5.96	2.98	1.49	0.43
Osteoblast - differentiated, donor2	11353-117H3	9.14	2.29	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	14.28	4.97	1.24	0.62
Osteoblast, donor1	11277-116H8	7.04	8.79	0.78	1.56
Osteoblast, donor2	11354-117H4	10.53	14.75	2.81	2.81
Osteoblast, donor3	11426-118G4	8.89	15.11	1.24	1.07
Pancreatic stromal cells, donor1	11249-116E7	11.03	8.26	1.18	1.26
Pericytes, donor1	11491-119E6	7.68	2.45	0.89	0.11
Pericytes, donor2	11571-120E5	17.43	2.49	1.58	0.00
Pericytes, donor3	11652-122E5	7.32	8.75	1.02	1.83
Perineurial Cells, donor1	11499-119F5	14.81	8.82	0.90	0.34
Perineurial Cells, donor2	11579-120F4	11.96	9.29	2.21	0.83
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	25.18	8.61	1.91	1.27
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	20.32	8.08	1.71	2.45
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	24.46	8.02	3.49	1.81
Placental Epithelial Cells, donor1	11278-116H9	8.13	3.59	0.72	0.24
Placental Epithelial Cells, donor2	11355-117H5	11.09	5.54	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	15.90	6.28	0.79	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	7.28	3.80	1.27	0.32
Preadipocyte - breast, donor1	11467-119B9	7.69	7.88	1.69	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	16.97	17.36	2.22	2.74
Preadipocyte - breast, donor2	11328-117E5	12.61	6.08	0.68	0.68
Preadipocyte - omental, donor1	11468-119C1	9.70	5.43	1.28	0.53
Preadipocyte - omental, donor2	11329-117E6	12.66	5.67	0.44	0.87
Preadipocyte - omental, donor3	11403-118D8	11.89	9.02	0.43	1.72
Preadipocyte - perirenal, donor1	11469-119C2	9.84	3.94	0.98	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	5.84	9.52	0.31	0.92
Preadipocyte - subcutaneous, donor2	11356-117H6	7.26	21.25	1.24	2.83
Preadipocyte - subcutaneous, donor3	11428-118G6	5.62	16.52	0.68	2.04
Preadipocyte - visceral, donor1	11280-116I2	8.20	15.09	1.02	1.86
Preadipocyte - visceral, donor2	11357-117H7	12.89	16.11	1.38	1.38
Preadipocyte - visceral, donor3	11429-118G7	8.36	10.76	0.31	1.46
Prostate Epithelial Cells (polarized), donor1	11253-116F2	12.37	13.58	2.26	1.21
Prostate Epithelial Cells, donor2	11331-117E8	10.70	7.18	1.35	1.08
Prostate Epithelial Cells, donor3	11404-118D9	18.92	4.23	0.55	0.24
Prostate Stromal Cells, donor1	11254-116F3	5.58	12.07	0.91	1.71
Prostate Stromal Cells, donor2	11332-117E9	11.12	10.22	0.90	1.26
Prostate Stromal Cells, donor3	11405-118E1	11.68	10.43	1.04	1.36
Renal Cortical Epithelial Cells, donor1	11516-119H4	6.20	3.65	0.73	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	13.10	5.13	1.04	0.28
Renal Epithelial Cells, donor1	11517-119H5	5.07	3.55	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	11.38	4.98	1.42	0.00
Renal Epithelial Cells, donor3	11678-122H4	15.46	4.34	1.16	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	8.17	5.45	0.00	2.72
Renal Glomerular Endothelial Cells, donor2	11594-120H1	5.12	6.74	0.40	2.96
Renal Glomerular Endothelial Cells, donor3	11675-122H1	15.54	11.54	1.78	1.78
Renal Glomerular Endothelial Cells, donor4	11783-124B1	7.32	2.00	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	7.70	4.84	1.76	0.88
Renal Mesangial Cells, donor2	11598-120H5	8.78	3.13	0.63	0.63
Renal Mesangial Cells, donor3	11679-122H5	9.43	1.11	0.55	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	8.05	8.86	2.15	0.81
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	4.64	5.48	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	8.49	4.44	0.77	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	11.93	1.81	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	7.96	5.12	1.99	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	9.26	3.09	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	7.53	2.51	0.75	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	31.81	8.69	1.07	0.94
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	45.56	4.47	1.79	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	15.41	6.05	2.75	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	20.30	5.80	2.32	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	38.36	7.54	1.30	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	41.91	8.34	1.89	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	25.32	12.16	2.45	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	32.75	5.83	1.61	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	38.11	7.69	1.86	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	43.22	7.86	1.16	1.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	44.63	7.39	0.96	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	38.88	8.32	0.91	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	31.54	9.14	2.69	1.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	45.05	7.89	1.15	1.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	34.88	5.79	1.29	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	31.42	8.85	2.21	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	43.59	4.97	1.91	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	46.40	6.71	1.68	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	26.49	9.58	2.82	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	52.15	5.31	1.33	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	40.10	7.98	2.43	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	34.37	7.07	3.82	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	44.43	4.91	1.28	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	37.56	8.13	0.84	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	34.69	8.20	1.20	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	53.42	4.56	0.55	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	36.67	6.25	2.21	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	27.94	9.00	1.75	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	34.67	6.13	0.94	1.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	36.31	6.94	1.79	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	29.00	9.82	2.57	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	36.91	6.43	1.87	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	33.40	8.18	1.33	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	34.47	8.98	1.46	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	43.07	4.98	1.62	1.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	47.34	7.83	2.72	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	34.51	9.64	2.12	0.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	39.72	6.53	1.38	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	41.84	7.13	1.37	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	39.89	10.51	1.64	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	48.74	4.09	1.19	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	33.73	8.58	1.18	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	45.85	8.53	2.40	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	52.68	4.84	1.24	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	38.33	4.29	1.19	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	67.11	6.65	1.41	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	40.87	4.14	1.22	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	41.92	6.99	2.79	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	42.91	5.74	3.32	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	42.47	5.26	1.10	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	75.98	15.87	8.15	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	31.64	6.69	0.61	1.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	44.00	5.73	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	32.12	8.82	1.58	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	31.75	9.88	2.10	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	21.49	7.56	1.65	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	19.42	9.39	2.35	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	23.44	9.62	2.40	0.00
Schwann Cells, donor1	11498-119F4	9.78	5.27	0.38	0.75
Schwann Cells, donor2	11578-120F3	3.40	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	11.39	7.23	0.66	1.10
Sebocyte, donor1	11220-116B5	8.22	18.62	1.64	1.10
Sebocyte, donor2	11301-117B5	9.65	8.73	0.92	1.84
Sebocyte, donor3	11378-118B1	24.32	3.50	0.21	0.00
Sertoli Cells, donor1	11255-116F4	13.25	14.91	1.66	0.00
Sertoli Cells, donor2	11333-117F1	31.07	5.65	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	18.48	11.09	2.64	0.79
Skeletal Muscle Cells, donor2	11358-117H8	12.29	0.00	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	30.93	8.36	0.84	5.85
Skeletal Muscle Cells, donor4	11451-119A2	13.82	9.43	1.41	1.10
Skeletal Muscle Cells, donor5	11455-119A6	13.82	9.66	0.59	0.45
Skeletal Muscle Cells, donor6	11459-119B1	15.24	15.70	1.08	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	14.87	17.51	2.39	1.39
Skeletal Muscle Satellite Cells, donor2	11321-117D7	17.69	13.27	1.57	0.86
Skeletal Muscle Satellite Cells, donor3	11397-118D2	16.77	21.63	2.68	1.19
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	18.20	13.65	2.44	1.52
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	11.58	7.24	0.72	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	13.90	8.53	1.10	0.96
Skin - palm, donor1	10286-104F7	34.92	18.80	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	11.82	3.17	0.86	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	123.50	37.62	6.54	9.81
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	12.98	6.36	0.52	1.04
Small Airway Epithelial Cells, donor1	11256-116F5	5.28	13.07	0.97	1.11
Small Airway Epithelial Cells, donor2	11334-117F2	12.80	12.80	1.13	0.84
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	78.23	58.57	6.98	3.17
Small Airway Epithelial Cells, donor3	11406-118E2	20.91	8.24	0.90	0.45
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	5.86	4.63	0.31	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	14.90	13.34	1.33	4.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	5.29	11.17	0.00	1.76
Smooth Muscle Cells - Aortic, donor1	11283-116I5	5.75	19.45	1.33	1.99
Smooth Muscle Cells - Aortic, donor2	11360-117I1	3.54	9.84	0.79	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	3.86	12.36	0.00	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	34.03	5.00	2.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	3.99	9.05	0.80	1.06
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	8.20	7.98	0.44	1.11
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	7.55	11.01	0.77	1.92
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	9.12	11.40	1.95	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	11.52	9.16	1.18	1.18
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	9.68	7.26	1.71	0.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	4.07	1.79	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	22.53	3.04	0.61	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	5.81	10.86	0.25	1.26
Smooth Muscle Cells - Carotid, donor2	11362-117I3	91.81	134.66	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	3.81	13.35	0.95	2.86
Smooth Muscle Cells - Colonic, donor1	11239-116D6	11.36	8.70	1.33	0.88
Smooth Muscle Cells - Colonic, donor2	11320-117D6	13.34	11.41	0.86	1.94
Smooth Muscle Cells - Colonic, donor3	11396-118D1	11.76	11.86	1.47	0.94
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	3.40	7.42	0.77	1.55
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	11.86	11.86	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	4.78	7.77	0.30	1.79
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	5.12	5.80	0.34	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	19.16	7.46	1.02	0.39
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	7.95	4.33	0.50	0.60
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	14.11	7.96	1.14	1.59
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	3.02	12.68	0.00	3.62
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	12.98	11.39	1.06	1.06
Smooth Muscle Cells - Prostate, donor1	11257-116F6	9.05	11.32	0.40	1.46
Smooth Muscle Cells - Prostate, donor2	11335-117F3	12.02	14.53	0.75	2.75
Smooth Muscle Cells - Prostate, donor3	11465-119B7	6.34	7.36	0.51	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	6.33	9.80	1.36	1.06
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	12.75	1.50	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	29.72	126.64	2.58	6.46
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	8.37	9.77	1.40	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	8.58	3.53	0.00	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	6.27	7.52	0.94	1.25
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	4.13	1.47	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	9.16	8.41	1.25	1.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	26.16	1.87	0.47	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	2.59	7.48	0.86	1.73
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	6.37	10.96	1.02	3.06
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	6.96	9.78	0.75	1.88
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	13.28	7.13	0.84	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	7.37	6.28	0.92	0.75
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	3.81	0.48	0.48	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	1.96	8.07	1.22	1.47
Smooth Muscle Cells - Uterine, donor1	11258-116F7	9.72	8.40	0.22	1.55
Smooth Muscle Cells - Uterine, donor3	11466-119B8	4.39	7.90	1.46	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	27.02	4.08	1.55	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	7.67	8.20	0.26	0.79
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	7.07	2.23	0.74	1.49
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	19.76	2.87	1.44	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	9.94	3.12	0.28	1.14
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	7.09	10.63	0.79	1.58
Smooth muscle cells - airway, control, donor1	11966-126D4	14.73	7.87	0.76	1.27
Smooth muscle cells - airway, control, donor2	11967-126D5	48.72	6.79	0.00	2.00
Smooth muscle cells - airway, control, donor3	11968-126D6	18.39	2.93	0.00	1.25
Smooth muscle cells - airway, control, donor4	11969-126D7	20.17	2.75	0.46	0.00
Synoviocyte, donor1	11291-117A4	9.93	9.26	1.18	1.35
Synoviocyte, donor2	11368-117I9	12.07	2.18	0.84	0.17
Synoviocyte, donor3	11440-118H9	19.66	2.01	0.67	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	17.51	7.15	1.43	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	3.96	1.98	3.96	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	17.60	4.63	1.85	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	4.87	10.54	0.93	0.93
Tracheal Epithelial Cells, donor2	11369-118A1	4.64	9.66	0.39	1.55
Tracheal Epithelial Cells, donor3	11441-118I1	5.73	14.32	0.00	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	29.03	8.00	1.48	1.35
Urethra, donor2	10319-105A4	28.77	3.60	0.00	0.00
Urothelial Cells, donor1	11520-119H8	4.52	4.25	0.53	0.53
Urothelial Cells, donor2	11600-120H7	4.01	6.41	0.80	0.80
Urothelial Cells, donor3	11681-122H7	7.11	4.58	0.46	0.69
Urothelial cells, donor0	11216-116B1	17.16	11.14	1.34	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	28.47	2.67	0.89	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	24.30	1.43	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	42.44	2.05	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	24.79	0.69	1.03	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	33.12	1.74	1.16	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	22.91	1.04	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	25.70	1.84	1.84	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	28.30	1.83	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	17.89	19.24	1.23	1.48
Wilms' tumor cell line:HFWT	10597-108E3	30.80	29.92	2.64	1.76
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	21.23	10.61	0.84	0.00
achilles tendon, donor2	10292-104G4	45.46	24.80	4.13	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	8.16	6.37	2.29	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	20.20	9.75	1.39	1.16
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	29.32	5.58	2.26	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	19.05	14.69	1.63	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	16.58	19.96	3.37	3.65
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	12.27	10.36	3.81	1.06
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	15.52	5.99	1.09	1.63
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	18.07	5.73	2.64	2.64
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	20.83	7.35	0.82	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	36.89	9.71	2.33	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	13.80	7.54	1.10	0.55
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	58.51	11.70	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	13.01	27.65	1.86	4.65
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	27.96	7.51	2.33	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	25.72	4.38	1.17	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	32.53	4.65	1.39	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	25.50	4.11	3.29	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	32.54	4.60	1.84	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	28.16	17.92	1.28	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	16.68	13.04	2.43	1.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	20.94	15.89	2.65	1.44
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	11.14	6.24	1.11	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	21.68	5.00	0.67	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	57.60	14.87	3.72	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	33.52	8.29	0.38	1.88
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	32.27	12.21	3.49	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	24.37	11.25	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	34.15	8.71	1.65	0.71
adipose tissue, adult, pool1	10010-101C1	16.29	5.12	0.78	0.31
adipose, donor1	10184-103D4	28.15	16.42	4.10	2.35
adipose, donor2	10185-103D5	56.77	15.82	3.65	1.62
adipose, donor3	10186-103D6	50.92	22.06	3.54	0.54
adipose, donor4	10187-103D7	207.15	88.41	5.20	2.60
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	26.04	7.42	0.16	0.79
adrenal gland, adult, pool1	10081-102A9	50.93	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	17.34	7.74	3.20	0.80
alveolar cell carcinoma cell line:SW 1573	10708-109H6	21.44	13.58	1.07	0.36
amniotic membrane cells, donor1	12235-129G3	18.32	3.71	0.70	0.23
amniotic membrane cells, donor2	12236-129G4	26.71	8.11	1.35	1.01
amniotic membrane cells, donor3	12237-129G5	20.62	2.36	0.29	0.29
amygdala - adult, donor10196	10167-103B5	46.25	2.37	1.19	2.37
amygdala, adult, donor10252	10151-102I7	92.06	5.27	1.42	0.41
amygdala, newborn, donor10223	10360-105E9	39.06	13.88	1.29	3.87
anaplastic carcinoma cell line:8305C	10428-106D5	25.34	8.02	2.55	0.76
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	19.19	26.70	4.19	3.97
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	70.82	12.36	3.01	1.00
aorta, adult, pool1	10052-101G7	41.19	6.67	1.37	0.59
appendix, adult	10189-103D9	37.26	10.09	1.94	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	16.16	6.19	1.03	0.69
artery, adult	10190-103E1	17.66	1.36	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	13.33	4.49	1.16	0.43
b cell line:RPMI1788	10427-106D4	24.24	19.63	3.72	1.93
basal cell carcinoma cell line:TE 354.T	10702-109G9	3.61	15.81	0.83	1.11
bile duct carcinoma cell line:HuCCT1	10432-106D9	9.72	11.71	1.89	1.09
bile duct carcinoma cell line:TFK-1	10496-107C1	9.37	21.76	1.34	2.34
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	15.10	4.47	1.12	0.00
bladder, adult, pool1	10011-101C2	25.86	4.02	1.74	0.33
blood, adult, pool1	10053-101G8	50.94	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	5.99	6.85	0.86	3.43
bone marrow, adult	10192-103E3	29.02	8.10	2.70	0.00
brain, adult, donor1	10084-102B3	39.98	4.10	1.03	1.03
brain, adult, pool1	10012-101C3	28.28	3.67	1.22	0.45
brain, fetal, pool1	10085-102B4	45.41	5.34	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	70.70	3.30	2.64	1.32
breast carcinoma cell line:MDA-MB-453	10419-106C5	41.82	3.12	1.00	0.37
breast, adult, donor1	10080-102A8	56.82	8.84	0.63	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	10.80	11.05	1.14	1.02
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	40.82	9.90	0.31	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	13.58	9.44	0.92	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	7.75	12.59	0.48	0.97
carcinoid cell line:NCI-H1770	10703-109H1	15.05	11.28	2.35	0.47
carcinoid cell line:NCI-H727	10735-110B6	20.02	8.86	1.75	1.42
carcinoid cell line:SK-PN-DW	10719-109I8	33.91	19.01	3.17	2.54
carcinosarcoma cell line:JHUCS-1	10642-109A3	38.06	37.80	3.19	1.60
caudate nucleus - adult, donor10196	10177-103C6	63.32	4.61	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	78.81	3.18	0.33	0.17
caudate nucleus, adult, donor10258	10379-105H1	53.49	4.58	1.53	0.76
caudate nucleus, newborn, donor10223	10354-105E3	36.26	9.52	1.83	5.49
cerebellum - adult, donor10196	10173-103C2	250.54	8.74	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	221.84	3.42	3.42	1.07
cerebellum, adult, pool1	10083-102B2	44.84	1.38	2.07	0.00
cerebellum, newborn, donor10223	10357-105E6	87.18	9.96	3.32	2.49
cerebral meninges, adult	10188-103D8	37.06	3.53	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	15.35	16.08	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	14.52	4.03	0.43	0.14
cervical cancer cell line:ME-180	10553-107I4	9.11	8.12	0.83	0.99
cervix, adult, pool1	10013-101C4	33.49	5.35	1.68	0.63
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	9.48	14.91	2.51	1.81
chondrosarcoma cell line:SW 1353	10700-109G7	14.37	5.23	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	23.74	3.98	0.99	0.25
choriocarcinoma cell line:SCH	10785-110H2	41.77	5.05	0.86	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	16.37	1.42	0.95	0.24
chorionic membrane cells, donor1	12238-129G6	18.52	3.70	0.28	0.28
chorionic membrane cells, donor2	12239-129G7	13.03	11.63	1.19	0.99
chorionic membrane cells, donor3	12240-129G8	33.52	2.75	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	5.05	1.01	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	14.79	11.91	1.54	1.73
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	14.78	15.21	1.90	1.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	43.40	27.73	2.57	1.80
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	45.23	29.51	3.39	4.35
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	38.28	30.34	2.24	2.44
chronic myelogenous leukemia cell line:K562	10454-106G4	19.43	23.85	2.65	2.94
chronic myelogenous leukemia cell line:KU812	10409-106B4	16.68	10.16	1.82	1.56
clear cell carcinoma cell line:JHOC-5	10638-108I8	18.52	15.77	1.37	1.60
clear cell carcinoma cell line:TEN	10636-108I6	9.89	7.98	1.39	0.87
colon carcinoma cell line:CACO-2	10513-107D9	7.69	19.59	1.46	0.92
colon carcinoma cell line:COLO-320	10420-106C6	44.47	5.70	4.18	0.00
colon, adult, donor1	10082-102B1	30.94	7.14	1.19	2.38
colon, adult, pool1	10014-101C5	13.16	7.17	2.23	0.47
colon, fetal, donor1	10070-101I7	64.89	8.03	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	233.76	4.58	18.33	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	1.70	98.16	9.77	20.40
cord blood derived cell line:COBL-a 24h infection	10453-106G3	1.06	47.24	2.57	7.70
cord blood derived cell line:COBL-a untreated	10449-106F8	3.10	51.05	3.53	11.99
corpus callosum, adult, pool1	10042-101F6	39.25	4.86	1.66	0.77
cruciate ligament, donor2	10295-104G7	42.95	19.45	1.62	0.81
diaphragm, fetal, donor1	10069-101I6	62.60	4.01	0.80	0.80
diencephalon, adult	10193-103E4	31.44	2.16	0.24	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	16.30	10.33	2.07	1.15
ductal cell carcinoma cell line:KLM-1	10438-106E6	21.28	5.39	1.80	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	6.74	8.67	0.96	0.48
ductus deferens, adult	10196-103E7	43.85	5.98	1.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	59.05	8.64	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	66.94	5.89	2.21	0.00
dura mater, adult, donor1	10041-101F5	18.00	13.21	4.54	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	13.99	17.99	3.11	6.66
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	9.46	7.45	2.15	1.15
embryonic pancreas cell line:1B2C6	10604-108F1	20.35	8.02	3.08	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	19.68	6.36	0.91	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	21.61	9.26	0.93	0.31
embryonic pancreas cell line:2C6	10603-108E9	22.33	5.25	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	11.06	18.10	1.34	2.35
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	20.84	17.22	1.81	0.91
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	12.06	4.66	0.48	0.32
epidermoid carcinoma cell line:A431	10426-106D3	8.89	5.56	1.45	0.89
epidermoid carcinoma cell line:Ca Ski	10431-106D8	14.96	9.79	2.42	0.99
epididymis, adult	10197-103E8	29.51	11.51	1.47	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	11.18	18.45	1.42	1.06
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	2.75	23.20	0.39	5.11
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	20.84	8.78	1.83	1.05
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	27.16	16.14	1.28	2.36
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	20.95	11.20	1.01	1.01
esophagus, adult, pool1	10015-101C6	13.48	4.25	0.64	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	38.07	6.39	1.88	0.63
eye - muscle inferior rectus, donor1	10272-104E2	26.56	12.07	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	21.04	16.83	4.21	0.00
eye - muscle medial, donor2	10299-104H2	32.74	5.95	0.00	0.00
eye - muscle superior, donor2	10297-104G9	20.64	3.44	2.29	1.15
eye - vitreous humor, donor1	10268-104D7	74.33	11.66	2.91	0.00
eye, fetal, donor1	10054-101G9	48.81	1.78	0.76	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	7.18	17.44	0.77	1.67
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	20.42	10.92	1.66	0.95
frontal lobe, adult, pool1	10040-101F4	34.81	4.88	2.06	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	38.43	9.91	2.40	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	10.70	10.15	1.83	1.19
gall bladder, adult	10198-103E9	23.66	3.14	1.21	0.48
gamma delta positive T cells, donor1	11937-126A2	25.77	5.37	2.68	0.00
gamma delta positive T cells, donor2	11938-126A3	22.04	1.87	1.49	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	16.90	4.44	1.48	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	9.09	36.75	2.71	4.26
gastric cancer cell line:AZ521	10549-107H9	18.36	36.40	2.13	3.12
gastric cancer cell line:GSS	10560-108A2	23.80	29.29	2.75	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	25.59	17.13	3.88	2.97
giant cell carcinoma cell line:LU65	10487-107B1	7.69	1.72	1.03	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	33.17	10.50	2.52	0.70
glassy cell carcinoma cell line:HOKUG	10688-109F4	21.45	18.21	1.75	2.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	11.72	15.73	2.32	1.27
glioblastoma cell line:A172, tech_rep2	10444-106F3	12.50	17.84	2.25	1.97
glioblastoma cell line:T98G	10485-107A8	4.19	27.04	1.99	2.87
glioma cell line:GI-1	10413-106B8	8.49	14.94	4.10	1.46
globus pallidus - adult, donor10196	10175-103C4	81.64	5.83	1.46	0.73
globus pallidus, adult, donor10252	10161-103A8	83.72	4.15	0.98	0.73
globus pallidus, adult, donor10258	10367-105F7	69.83	4.11	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	33.57	6.93	1.07	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	159.06	12.24	9.79	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	21.86	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	11.84	5.44	0.32	0.64
hIPS +CCl2, biol_rep1	14383-156B9	70.70	18.36	1.38	0.46
hIPS +CCl2, biol_rep2	14384-156C1	46.18	10.06	1.37	1.37
hIPS +CCl2, biol_rep3	14385-156C2	72.78	9.66	0.64	0.64
hIPS, biol_rep1	14380-156B6	56.05	4.31	5.75	2.87
hIPS, biol_rep2	14381-156B7	69.96	12.35	2.06	0.69
hIPS, biol_rep3	14382-156B8	38.62	3.31	3.31	0.00
hairy cell leukemia cell line:Mo	10712-109I1	9.77	9.19	0.57	0.00
heart - mitral valve, adult	10205-103F7	30.20	6.58	1.79	1.20
heart - pulmonic valve, adult	10206-103F8	33.21	7.06	1.31	0.52
heart - tricuspid valve, adult	10207-103F9	82.43	5.83	2.50	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	20.81	5.71	0.82	0.61
heart, adult, diseased, donor1	10051-101G6	22.57	2.55	0.43	0.43
heart, adult, pool1	10016-101C7	14.72	1.15	1.15	0.00
heart, fetal, pool1	10046-101G1	39.12	6.98	2.05	0.72
hepatic mesenchymal tumor cell line:LI90	10778-110G4	15.43	14.19	0.93	3.09
hepatoblastoma cell line:HuH-6	10633-108I3	29.73	7.14	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	19.34	20.44	3.43	2.10
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	16.63	22.45	1.94	2.43
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	18.90	24.56	2.02	3.23
hepatoma cell line:Li-7	10484-107A7	5.34	17.13	1.22	2.78
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	14.47	18.59	1.91	1.41
hippocampus - adult, donor10196	10169-103B7	54.89	5.68	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	93.07	5.51	1.22	0.61
hippocampus, adult, donor10258	10374-105G5	37.84	2.99	1.00	0.00
hippocampus, newborn, donor10223	10363-105F3	47.94	5.29	0.70	1.76
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	39.67	9.16	0.61	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	62.64	4.52	0.79	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	47.99	9.39	1.52	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	71.05	19.74	3.38	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	77.21	14.98	3.36	2.58
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	49.35	15.56	3.80	2.28
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	39.41	22.19	4.09	1.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	48.47	14.65	2.15	0.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	36.70	18.77	2.92	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	11.84	8.05	1.66	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	23.79	5.30	2.73	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	17.51	7.41	3.37	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	64.00	6.10	1.56	1.10
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	69.76	6.39	1.97	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	38.40	4.36	0.00	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	79.99	17.95	3.82	0.76
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	78.49	10.47	3.49	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	36.98	14.99	4.50	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	53.69	20.72	2.45	3.20
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	49.11	20.92	4.09	1.82
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	43.23	24.75	7.20	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	19.92	5.88	1.96	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	19.45	4.35	1.45	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	20.63	5.38	3.29	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	64.85	7.94	1.85	1.48
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	63.05	8.27	1.43	3.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	45.32	9.80	7.76	2.04
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	35.21	14.44	2.46	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	36.74	12.99	2.85	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	27.84	16.64	3.63	2.72
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	27.92	19.13	3.62	2.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	30.55	15.94	0.66	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	18.98	9.75	2.05	1.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	13.80	7.41	1.53	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	19.69	4.54	2.27	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	12.43	10.42	2.69	1.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	58.44	8.45	1.69	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	45.01	9.36	1.78	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	58.54	10.24	1.95	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	54.40	14.06	2.44	1.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	13.01	48.80	22.77	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	23.50	23.50	5.63	2.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	45.97	15.87	5.47	2.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	28.59	16.65	3.98	3.62
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	29.54	16.73	2.85	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	15.51	7.16	3.58	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	14.76	9.07	2.57	1.08
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	14.82	11.31	2.69	0.81
immature langerhans cells, donor1	11904-125F5	13.32	22.28	3.39	3.15
immature langerhans cells, donor2	11905-125F6	27.72	21.39	3.96	3.17
insula, adult, pool1	10039-101F3	30.09	6.81	2.56	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	2.60	2.93	0.00	0.65
kidney, adult, pool1	10017-101C8	14.32	4.81	1.20	0.60
kidney, fetal, pool1	10045-101F9	31.19	6.15	1.13	0.21
large cell lung carcinoma cell line:IA-LM	10509-107D5	21.16	5.54	2.27	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	5.94	4.01	1.24	0.55
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	29.18	5.14	0.55	0.00
left atrium, adult, donor1	10079-102A7	26.15	2.72	0.54	0.00
left ventricle, adult, donor1	10078-102A6	22.75	2.53	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	15.05	26.81	1.64	1.09
leiomyoma cell line:10964C	10569-108B2	7.18	0.72	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	5.43	3.26	0.54	0.00
leiomyoma cell line:15425	10571-108B4	6.31	2.43	0.00	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	18.82	6.27	2.09	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	13.81	13.93	3.42	0.94
liposarcoma cell line:KMLS-1	10782-110G8	8.44	18.28	1.41	0.62
liposarcoma cell line:SW 872	10726-110A6	13.52	14.01	1.58	2.31
liver, adult, pool1	10018-101C9	14.10	8.27	0.97	0.81
liver, fetal, pool1	10086-102B5	25.40	4.70	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	64.45	2.48	0.44	0.58
locus coeruleus, adult, donor10252	10165-103B3	64.78	2.77	0.92	0.00
locus coeruleus, adult, donor10258	10375-105G6	28.78	2.82	0.56	0.85
locus coeruleus, newborn, donor10223	10362-105F2	27.34	3.79	0.42	1.26
lung adenocarcinoma cell line:A549	10499-107C4	6.23	12.04	1.25	0.97
lung adenocarcinoma cell line:PC-14	10408-106B3	17.24	5.52	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	10.68	22.15	1.32	2.50
lung, adult, pool1	10019-101D1	18.31	6.38	1.89	0.24
lung, fetal, donor1	10068-101I5	82.20	12.84	1.71	1.71
lung, right lower lobe, adult, donor1	10075-102A3	33.91	5.96	1.83	1.37
lymph node, adult, donor1	10077-102A5	45.44	3.79	0.95	0.00
lymphangiectasia cell line:DS-1	10727-110A7	8.11	4.82	0.88	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	2.57	9.51	1.66	0.91
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	23.79	24.64	0.00	3.40
mature adipocyte, donor1	12231-129F8	20.87	3.11	0.89	1.78
mature adipocyte, donor2	12232-129F9	20.96	5.40	2.49	0.42
mature adipocyte, donor3	12233-129G1	17.54	7.35	2.13	0.47
mature adipocyte, donor4	12234-129G2	17.64	3.95	1.58	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	34.31	18.58	4.05	2.62
medial frontal gyrus - adult, donor10196	10170-103B8	78.96	1.13	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	98.76	3.13	0.92	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	49.56	3.18	1.27	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	36.68	6.40	2.13	4.26
medial temporal gyrus - adult, donor10196	10183-103D3	75.26	3.88	1.01	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	113.54	3.18	0.42	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	30.82	0.00	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	14.35	28.71	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	48.46	8.97	3.59	2.15
medulla oblongata - adult, donor10196	10174-103C3	42.83	3.89	0.65	1.30
medulla oblongata, adult, donor10252	10155-103A2	79.72	4.33	0.77	0.46
medulla oblongata, adult, pool1	10038-101F2	30.69	5.14	1.88	0.73
medulla oblongata, newborn, donor10223	10361-105F1	45.48	5.55	0.69	1.39
medulloblastoma cell line:D283 Med	10838-111E1	97.20	15.28	6.64	1.33
medulloblastoma cell line:ONS-76	10759-110E3	14.43	10.76	1.10	1.35
melanoma cell line:COLO 679	10514-107E1	4.74	8.77	1.44	2.44
melanoma cell line:G-361	10465-106H6	4.34	17.37	1.90	1.90
meningioma cell line:HKBMM	10691-109F7	11.94	3.08	0.90	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	43.18	22.03	5.29	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	52.36	7.78	2.33	1.04
mesenchymal precursor cell - adipose, donor1	11747-123G1	3.99	20.41	0.61	1.84
mesenchymal precursor cell - adipose, donor2	11748-123G2	3.45	17.27	0.55	3.09
mesenchymal precursor cell - adipose, donor3	11749-123G3	7.04	5.38	0.83	2.07
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	4.07	3.23	0.42	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	6.35	10.40	0.39	0.77
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	13.88	4.86	1.39	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	4.81	3.78	0.86	0.69
mesenchymal precursor cell - cardiac, donor2	11753-123G7	6.90	7.13	0.92	0.81
mesenchymal precursor cell - cardiac, donor3	11754-123G8	5.17	13.00	1.19	1.72
mesenchymal precursor cell - cardiac, donor4	11755-123G9	6.35	7.97	1.49	1.89
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	5.55	16.50	0.57	2.13
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	8.89	10.54	1.32	0.99
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	4.70	17.02	1.52	1.52
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	9.43	12.22	1.40	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	4.70	9.39	0.41	1.02
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	7.91	24.08	1.44	1.80
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	6.31	6.31	0.62	1.03
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	6.38	6.61	0.46	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	3.36	9.65	0.84	4.62
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	6.28	13.45	0.45	1.79
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	3.41	13.39	0.79	2.01
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	9.20	11.41	1.84	2.21
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	8.01	20.32	1.14	4.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	9.68	9.26	1.26	2.11
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	10.05	6.85	0.46	2.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	7.42	5.63	0.77	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	7.85	8.11	1.83	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	10.17	10.78	0.92	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	5.41	6.83	1.18	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	6.77	11.51	1.02	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	7.07	5.11	1.18	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	7.88	7.41	0.93	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	48.30
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	10.38	7.50	1.15	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	6.69	7.81	0.45	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	6.73	5.53	0.48	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	9.53	13.93	1.47	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	4.70	5.37	1.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	4.91	7.78	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	5.58	7.30	0.86	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	13.67	5.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	8.12	6.50	1.30	1.30
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	7.27	5.82	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	10.13	9.06	1.60	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	9.81	4.09	0.00	4.09
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	7.77	8.55	2.33	1.17
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	8.39	4.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	12.92	0.00	0.99	2.98
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	9.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	14.82	5.34	0.59	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	4.87	2.44	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	8.87	4.43	0.63	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	12.76	2.07	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	19.34	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	6.93	2.85	1.22	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	5.56	3.97	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	8.25	4.13	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	12.16	2.49	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	13.37	0.00	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	10.64	1.18	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	12.84	2.57	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	13.08	2.07	2.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	11.38	4.45	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	10.09	2.24	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	5.72	2.54	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	13.70	3.22	0.81	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	15.26	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	15.20	3.80	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	13.35	7.28	0.00	1.82
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	22.59	0.00	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	16.47	5.77	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	9.52	2.98	0.40	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	11.68	2.92	0.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	16.30	2.04	2.04	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	17.80	3.09	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	16.54	10.39	1.65	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	14.36	28.03	1.85	6.26
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	8.55	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	2.57	11.51	0.72	1.64
mesothelioma cell line:Mero-25	10850-111F4	10.67	14.30	2.50	2.72
mesothelioma cell line:Mero-41	10851-111F5	10.27	29.58	2.44	3.67
mesothelioma cell line:Mero-48a	10852-111F6	14.39	3.76	0.44	0.89
mesothelioma cell line:Mero-82	10853-111F7	6.31	20.50	1.31	3.94
mesothelioma cell line:Mero-83	10854-111F8	18.38	12.09	1.53	2.21
mesothelioma cell line:Mero-84	10855-111F9	6.32	6.57	0.51	0.51
mesothelioma cell line:Mero-95	10856-111G1	14.70	5.80	0.41	1.04
mesothelioma cell line:NCI-H2052	10847-111F1	12.59	5.30	0.17	0.50
mesothelioma cell line:NCI-H226	10846-111E9	6.15	15.93	0.90	1.99
mesothelioma cell line:NCI-H2452	10848-111F2	8.03	7.52	1.71	0.68
mesothelioma cell line:NCI-H28	10845-111E8	19.08	14.25	0.25	2.80
mesothelioma cell line:No36	10857-111G2	8.16	8.16	0.33	1.30
mesothelioma cell line:ONE58	10858-111G3	5.69	12.19	0.81	4.06
migratory langerhans cells, donor1	11901-125F2	11.32	14.78	3.07	0.38
migratory langerhans cells, donor2	11902-125F3	9.16	11.36	1.95	1.22
migratory langerhans cells, donor3	11903-125F4	15.08	7.36	2.69	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	19.92	3.92	1.31	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	20.35	18.01	1.48	3.39
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	13.13	11.06	1.15	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	5.71	11.42	1.90	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	19.40	5.54	2.22	0.74
myeloma cell line:PCM6	10474-106I6	6.92	11.27	1.19	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	31.96	5.58	0.00	2.03
myxofibrosarcoma cell line:NMFH-1	10684-109E9	9.81	11.57	1.77	1.77
nasal epithelial cells, donor1, tech_rep1	12226-129F3	12.93	4.35	0.56	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	10.37	4.27	1.10	0.00
nasal epithelial cells, donor2	12227-129F4	40.30	52.44	2.21	3.86
neuroblastoma cell line:CHP-134	10508-107D4	41.64	10.35	4.83	0.92
neuroblastoma cell line:NB-1	10539-107G8	55.00	18.90	5.99	1.87
neuroblastoma cell line:NBsusSR	10607-108F4	17.71	5.06	4.01	0.42
neuroblastoma cell line:NH-12	10555-107I6	56.84	6.52	3.17	0.56
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	33.69	2.85	1.66	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	22.17	11.88	3.64	2.53
neuroectodermal tumor cell line:TASK1	10774-110F9	22.54	11.47	3.02	0.60
neuroepithelioma cell line:SK-N-MC	10728-110A8	30.52	5.09	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	19.96	15.44	1.60	2.40
neutrophil PMN, donor1	12133-128D9	29.75	0.00	0.00	14.87
neutrophil PMN, donor2	12137-128E4	0.00	0.00	13.28	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	55.98	30.44	4.23	1.52
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	12.81	4.80	0.80	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	17.95	7.69	1.92	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	9.99	8.15	0.26	2.10
nucleus accumbens, adult, pool1	10037-101F1	35.43	5.44	1.59	0.47
occipital cortex - adult, donor10196	10172-103C1	109.20	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	133.38	3.22	0.54	0.81
occipital cortex, newborn, donor10223	10355-105E4	57.50	6.55	4.00	2.18
occipital lobe, adult, donor1	10076-102A4	32.28	4.72	1.31	0.26
occipital lobe, fetal, donor1	10073-102A1	109.85	4.29	0.43	0.43
occipital pole, adult, pool1	10036-101E9	25.62	1.81	1.42	0.24
olfactory region, adult	10195-103E6	66.30	2.10	1.15	0.00
optic nerve, donor1	10277-104E7	56.03	6.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	19.59	7.86	2.28	0.91
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	18.82	7.69	0.41	0.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	4.91	3.56	0.17	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	8.32	34.54	2.08	2.31
osteoclastoma cell line:Hs 706.T	10704-109H2	14.99	8.82	2.35	1.18
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	5.61	4.67	0.00	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	13.15	7.85	1.48	0.85
ovary, adult, pool1	10020-101D2	26.47	4.37	2.01	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	17.97	11.55	1.10	1.65
pancreas, adult, donor1	10049-101G4	34.80	4.70	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	34.38	3.07	0.84	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	10.73	5.62	1.02	1.36
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	10.27	9.77	2.32	0.99
paracentral gyrus, adult, pool1	10035-101E8	35.51	3.66	1.74	0.46
parietal cortex, adult, donor10258	10373-105G4	75.60	24.96	2.94	0.00
parietal lobe - adult, donor10196	10171-103B9	83.70	4.70	1.88	0.00
parietal lobe, adult, donor10252	10157-103A4	110.31	3.14	0.86	0.29
parietal lobe, adult, pool1	10034-101E7	39.39	3.17	1.59	0.18
parietal lobe, fetal, donor1	10072-101I9	113.47	7.76	1.94	0.97
parietal lobe, newborn, donor10223	10356-105E5	42.99	12.34	1.12	2.24
parotid gland, adult	10199-103F1	45.02	5.55	1.23	1.23
penis, adult	10200-103F2	26.86	3.76	1.07	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	18.04	4.65	0.37	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	15.44	13.26	1.89	2.62
pineal gland - adult, donor10196	10179-103C8	94.17	3.23	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	77.58	5.33	1.18	0.59
pineal gland, adult, donor10258	10377-105G8	62.71	8.15	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	125.46	15.18	1.01	1.01
pituitary gland, adult, donor10252	10162-103A9	131.34	9.90	3.65	0.00
pituitary gland, adult, donor10258	10378-105G9	70.65	5.96	0.85	0.00
placenta, adult, pool1	10021-101D3	30.96	4.19	1.94	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	15.63	17.35	2.65	2.52
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	34.86	23.35	4.98	2.18
pons, adult, pool1	10033-101E6	21.26	4.39	1.98	0.52
postcentral gyrus, adult, pool1	10032-101E5	25.89	2.79	1.22	0.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	96.20	14.64	4.18	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	7.72	11.22	0.87	1.02
prostate cancer cell line:PC-3	10439-106E7	20.51	12.71	3.45	1.27
prostate, adult, pool1	10022-101D4	27.03	2.54	1.18	0.09
putamen, adult, donor10196	10176-103C5	79.32	4.25	0.00	0.71
putamen, adult, donor10252	10152-102I8	58.82	5.88	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	43.71	0.00	2.19	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	51.22	3.38	0.24	0.24
putamen, newborn, donor10223	10365-105F5	13.49	3.75	0.75	1.50
rectal cancer cell line:TT1TKB	10469-106I1	9.02	2.91	0.29	0.58
rectum, fetal, donor1	10067-101I4	52.86	15.30	1.39	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	6.36	14.20	1.06	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	7.46	19.88	0.83	0.83
retina, adult, pool1	10030-101E3	38.27	4.87	2.39	0.40
retinoblastoma cell line:Y79	10475-106I7	28.58	23.64	4.68	1.82
rhabdomyosarcoma cell line:KYM-1	10787-110H4	19.92	16.84	1.72	0.49
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	33.74	28.12	4.22	1.12
sacrococcigeal teratoma cell line:HTST	10695-109G2	17.43	12.13	0.00	3.79
salivary acinar cells, donor1	11771-123I7	11.33	7.61	2.10	0.81
salivary acinar cells, donor2	11772-123I8	16.66	5.92	1.38	0.69
salivary acinar cells, donor3	11773-123I9	36.41	5.96	0.00	0.66
salivary gland, adult, pool1	10093-102C3	25.74	5.72	2.86	1.72
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	10.29	3.71	1.01	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	9.76	3.41	0.94	0.24
seminal vesicle, adult	10201-103F3	38.62	11.11	1.06	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	33.28	8.99	0.97	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	10.57	6.29	1.26	1.01
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	14.05	13.05	1.00	3.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	20.28	2.01	0.67	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	7.74	19.34	2.65	3.09
signet ring carcinoma cell line:NUGC-4	10483-107A6	3.74	44.64	1.03	9.29
skeletal muscle - soleus muscle, donor1	10282-104F3	11.35	2.13	0.71	0.71
skeletal muscle, adult, pool1	10023-101D5	14.75	2.04	0.48	0.00
skeletal muscle, fetal, donor1	10066-101I3	59.30	6.03	1.01	0.00
skin, adult, donor1	10074-102A2	40.71	13.57	6.79	0.00
skin, fetal, donor1	10065-101I2	34.72	9.47	0.63	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	40.02	20.68	1.67	2.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	46.34	16.71	4.41	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	26.02	18.70	2.70	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	29.17	10.22	3.63	1.48
small cell lung carcinoma cell line:NCI-H82	10842-111E5	65.63	4.50	0.97	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	35.30	23.54	6.10	4.79
small intestine, adult, pool1	10024-101D6	17.44	11.11	2.75	1.07
small intestine, fetal, donor1	10064-101I1	45.70	4.91	0.98	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	5.13	15.39	2.56	4.62
smooth muscle, adult, pool1	10048-101G3	31.53	3.10	1.03	0.00
somatostatinoma cell line:QGP-1	10781-110G7	29.48	15.55	2.14	6.70
spinal cord - adult, donor10196	10181-103D1	67.45	4.13	0.69	0.92
spinal cord, adult, donor10252	10159-103A6	67.03	3.55	0.39	1.58
spinal cord, adult, donor10258	10369-105F9	31.13	2.08	0.69	0.69
spinal cord, fetal, donor1	10056-101H2	53.06	7.93	1.22	0.61
spinal cord, newborn, donor10223	10359-105E8	36.74	5.51	1.84	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	13.44	12.10	1.05	1.34
spleen, adult, pool1	10025-101D7	22.47	5.40	1.76	0.22
spleen, fetal, pool1	10044-101F8	16.37	6.75	1.99	0.95
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	7.76	18.84	2.48	1.66
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	8.92	7.22	1.14	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	20.97	10.83	2.10	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	11.34	1.17	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	11.03	1.46	0.45	0.45
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	8.05	12.28	0.85	1.27
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	35.54	39.77	6.77	2.12
stomach, fetal, donor1	10062-101H8	58.74	17.09	1.07	2.14
submaxillary gland, adult	10202-103F4	49.56	3.99	1.71	0.00
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	61.48	2.70	0.42	0.42
substantia nigra, adult, donor10258	10371-105G2	50.69	3.62	1.55	0.52
substantia nigra, newborn, donor10223	10358-105E7	56.53	2.83	0.71	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	28.43	8.25	1.60	0.69
temporal lobe, adult, pool1	10031-101E4	28.74	2.88	1.36	0.42
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	123.22	6.41	0.71	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	80.44	4.83	1.32	0.88
tenocyte, donor1	11763-123H8	16.41	4.19	3.14	0.00
tenocyte, donor2	11765-123I1	18.69	2.29	0.00	0.38
tenocyte, donor3	11768-123I4	15.20	1.48	0.00	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	46.91	11.73	2.89	0.85
teratocarcinoma cell line:NCR-G1	10798-110I6	35.61	16.96	3.70	1.70
teratocarcinoma cell line:PA-1	10807-111A6	26.97	10.23	2.48	1.24
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	43.67	6.09	2.41	1.27
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	34.41	2.65	1.13	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	16.47	4.25	0.44	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	55.04	2.93	2.61	0.98
testis, adult, pool1	10026-101D8	29.74	8.38	1.07	0.43
testis, adult, pool2	10096-102C6	65.41	8.12	0.90	2.26
thalamus - adult, donor10196	10168-103B6	66.24	6.62	1.10	0.00
thalamus, adult, donor10252	10154-103A1	74.70	2.97	1.41	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	23.09	0.00	1.54	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	42.00	3.46	0.66	0.49
thalamus, newborn, donor10223	10366-105F6	29.34	6.33	1.73	4.60
throat, adult	10209-103G2	19.22	4.24	0.75	0.00
throat, fetal, donor1	10061-101H7	88.06	7.62	1.22	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	42.93	14.51	3.18	1.59
thymus, adult, pool1	10027-101D9	40.66	5.87	1.59	0.40
thymus, fetal, pool1	10043-101F7	35.64	9.14	3.22	0.94
thyroid carcinoma cell line:KHM-5M	10776-110G2	8.78	11.30	2.13	2.53
thyroid carcinoma cell line:TCO-1	10783-110G9	21.23	12.85	1.96	1.40
thyroid, adult, pool1	10028-101E1	31.63	4.67	1.21	0.28
thyroid, fetal, donor1	10060-101H6	97.03	6.59	1.05	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	27.72	12.32	3.08	0.00
tongue, adult	10203-103F5	16.51	6.98	1.63	0.47
tongue, fetal, donor1	10059-101H5	52.41	2.36	0.79	0.00
tonsil, adult, pool1	10047-101G2	12.02	8.92	3.61	0.50
trachea, adult, pool1	10029-101E2	18.32	6.71	1.80	0.33
trachea, fetal, donor1	10058-101H4	87.71	4.23	1.54	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	10.98	11.69	0.71	2.13
transitional-cell carcinoma cell line:5637	10418-106C4	46.71	209.62	21.58	22.90
transitional-cell carcinoma cell line:JMSU1	10492-107B6	27.26	18.65	2.66	0.78
tridermal teratoma cell line:HGRT	10694-109G1	19.03	9.51	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	8.30	3.56	1.02	0.25
umbilical cord, fetal, donor1	10057-101H3	37.56	6.26	2.09	0.00
uterus, adult, pool1	10100-102D1	36.34	4.27	2.22	0.34
uterus, fetal, donor1	10055-101H1	76.28	5.12	1.54	0.00
vagina, adult	10204-103F6	70.44	3.88	1.29	0.65
vein, adult	10191-103E2	45.15	2.85	2.63	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	8.01	12.55	1.07	0.53